Clinical Trial Update: Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study [Phase 3]

View source ↗

Summary

Phase 3 MEMORY study comparing mepolizumab to placebo in eosinophilic asthma has been terminated, with results on airway physiology not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Asthma | Phase 3 | Status: TERMINATED